International Clinical Trial: Open-label Extension Study in Participants With Early Alzheimer's Disease

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07105709) titled 'Open-label Extension Study in Participants With Early Alzheimer's Disease' on Aug. 1.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: GlaxoSmithKline

Condition: Alzheimer's Disease

Intervention: Drug: GSK4527226

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: August 11, 2025

Target Sample Size: 226

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07105709

Published by HT Digital Content Services with permission from Health Daily Digest....